A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Clinical trial NCT07441278 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07441278
Sponsor: NS Pharma, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Start date: 2026-07-01
Primary completion: 2028-09-14
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.